The pharmaceutical landscape is witnessing a shift with the introduction of GLP-1 delivery devices. These innovative formulations offer a potential alternative to delivering glucagon-like peptide-1 therapies https://tasneemsrsw523840.blogsumer.com/39864231/glp-1-patches-a-revolutionary-way-to-control-diabetes